PHARMACOKINETICS OF TOTAL AND FREE VALPROIC ACID DURING MONOTHERAPY IN INFANTS

被引:13
作者
HERNGREN, L [1 ]
LUNDBERG, B [1 ]
NERGARDH, A [1 ]
机构
[1] KAROLINSKA HOSP,DEPT PAEDIAT,S-10401 STOCKHOLM 60,SWEDEN
关键词
VALPROIC ACID; INFANTS; PROTEIN BINDING; PHARMACOKINETICS;
D O I
10.1007/BF00315328
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pharmacokinetics of free and total valproic acid (VPA) in plasma and whole blood after oral administration during steady state was investigated in seven infants (mean age 10.7 months) receiving monotherapy. The VPA concentrations in whole blood closely followed those in plasma but at a reduced level. A positive correlation was found between dose and mean plasma concentration (r = 0.71). Mean terminal half-lives were similar in plasma and whole blood (12.5 and 15.5 h, respectively), but were considerably longer than for free VPA (6.4 and 6.5 h, respectively; P < 0.01). There was a significant decrease in half-lives with increasing age (P < 0.05). Plasma and whole blood clearance for total VPA was higher than reported in older infants and adults (17.8 and 28.9 ml/kg per hour) and was considerably higher for free VPA (127.6 and 188.8 ml/kg per hour, respectively). The increase in clearance compared with that in older subjects is well in concordance with a lower protein binding of VPA (mean 85.3%). Of special importance is that the percentage of unbound VPA increased with increasing concentrations of total VPA. The fraction of unbound VPA in plasma increased even more in subjects with low albumin concentrations (P < 0.01).
引用
收藏
页码:315 / 319
页数:5
相关论文
共 20 条
  • [1] VALPROIC ACID DOSAGE AND PLASMA-PROTEIN BINDING AND CLEARANCE
    BOWDLE, TA
    PATEL, IH
    LEVY, RH
    WILENSKY, AJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) : 486 - 492
  • [2] BRUNI J, 1978, CLIN PHARMACOL THER, V24, P324
  • [3] VALPROIC ACID HEPATIC FATALITIES - A RETROSPECTIVE REVIEW
    DREIFUSS, FE
    SANTILLI, N
    LANGER, DH
    SWEENEY, KP
    MOLINE, KA
    MENANDER, KB
    [J]. NEUROLOGY, 1987, 37 (03) : 379 - 385
  • [4] EHRNEBO M, 1974, CLIN PHARMACOL THER, V16, P434
  • [5] GAMSTORP I, 1985, PAEDIATRIC NEUROLOGY, P114
  • [6] Gibaldi M., 1982, PHARMACOKINETICS, Vsecond
  • [7] PLASMA-PROTEIN BINDING OF VALPROIC ACID IN HEALTHY SUBJECTS AND IN PATIENTS WITH RENAL-DISEASE
    GUGLER, R
    MUELLER, G
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (05) : 441 - 446
  • [8] PHARMACOKINETICS OF FREE AND TOTAL SODIUM VALPROATE IN ADOLESCENTS AND YOUNG-ADULTS DURING MAINTENANCE THERAPY
    HERNGREN, L
    NERGARDH, A
    [J]. JOURNAL OF NEUROLOGY, 1988, 235 (08) : 491 - 495
  • [9] PLASMA-CONCENTRATIONS OF UNBOUND VALPROATE AND THE MANAGEMENT OF EPILEPSY
    KILPATRICK, CJ
    BURY, RW
    FULLINFAW, RO
    MOULDS, RFW
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1987, 17 (06): : 574 - 579
  • [10] KRIEL RL, 1979, ANN NEUROL, V6, P179